Deutz is a leading non-captive engine manufacturer for a wide range of customer industries with a strong and very well-known brand. The company will enter a profitable growth period soon (CAGR 2023-26e sales 8%, EPS 18%). We initiate coverage with an Outperform rating and a target price of € 7.9, reflecting >40% upside from here. - ...
Deutz is a leading non-captive engine manufacturer for a wide range of customer industries with a strong and very well-known brand. The company will enter a profitable growth period soon (CAGR 2023-26e sales 8%, EPS 18%). We initiate coverage with an Outperform rating and a target price of € 7.9, reflecting >40% upside from here. - ...
>Q1 sales 12% above our forecasts - Lisi has reported Q1 sales of € 449.3m (€ 430.7m est.) vs € 401.3m, up 11.9% and 12.5% organically. These sales were well above our forecasts, mainly thanks to the excellent showing in aerospace. This was also a good performance in view of the demanding comparison base (+15%). The Aerospace division posted organic growth of 27%, driven by the higher production rate of single-aisle versions of the A320. Full-year target...
>CA T1 supérieur à nos attentes de 12% - Lisi publie un CA T1 de 449.3 M€ (430.7 M€ estimés) vs 401.3 M€ en hausse de 11.9% et +12.5% en organique. Ce CA est largement supérieur à nos attentes principalement du fait des très bonnes performances dans l’aéronautique. Il s’agit de surcroît d’une bonne performance alors que l’effet de référence était soutenu (+15%). Ainsi, la division Aerospace affiche une hausse organique de +27% portée par l’accroissement des cadences d...
Despite a still highly inflationary environment, Lisi improved its EBIT in absolute terms and generated a positive FCF that exceeded our expectationsBarring a catastrophe, the 2024 financial year will still see sustained growth thanks to the very good momentum in aeronauticsThe improvement in EBIT margin seen in H2 should continue in 2024 under the effect of price increases and the stabilisation of raw material pricesEarnings growth momentum is once again favourable and multiples are becoming af...
>Operating results close to our forecasts - Sales were up 14.4%, +15.5% organically. This very strong momentum, homogeneous across quarters, lifted all three business units and benefited from a price effect. This is a good performance despite the base effect (+15.5% in 2022). The underlying operating profit edged up 1.8%, implying an underlying operating margin of 5.5% (5.8% estimated, 5.5% for consensus) vs 6.3% (-80bp), as H1 was under pressure. FCF is positive at a...
>Des résultats opérationnels proches de nos attentes - Le CA affiche une hausse de 14.4% et de 15.5% en organique. Cette très forte dynamique a été homogène entre les différents trimestres, a concerné les 3 activités et a également bénéficié d’un effet prix. Il s’agit d’une bonne performance malgré l’effet de référence (+15.5% en 2022). Le ROC affiche une légère hausse de 1.8% soit une MOPC de 5.5% (5.8% estimés, 5.5% pour le Css) vs 6.3% (-80 pb) du fait d’un S1 sous...
A date, il nous semble un peu tôt pour pleinement repondérer les Midcaps en raison du timing de la baisse des taux que nos économistes/stratégistes situent à mi-2024, mais : i/ les valorisations (PE 24e : 12,5x - VE/EBITDA 24e : 6,3x) offrent, ponctuellement au moins, des opportunités (décote proche de 30% par rapport aux Large caps), ii/ la croissance attendue est de ~4% (CA 24e) et 8% sur l’EBITDA 24e, iii/ l’approche de la détente des taux amorce un changement dans la percepti...
A director at LISI Group sold 1,900,000 shares at 21.000EUR and the significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
Q3 sales up 15% organically, in line with our expectations Inflation pass-through target on track to be achievedEBIT growth target in absolute terms confirmed, but still challengingStrong visibility in aerospace and medical sectors, but uncertainties in the automotive sectorSlight downward adjustment to our forecasts and price targetADD opinion: a quality stock, but not as discounted as other manufacturers.
>Q3 sales close to our expectations - Lisi published Q3 sales of € 396.2m (€ 407.3me) vs € 355.8m, up 11.3% and +14.8% organic. This performance compares with interim organic growth of 17.4%. Note that for this quarter, the reference effect was particularly unfavourable with an organic increase of 24.4% for the reference quarter. 9-month sales came to € 1,217.9m vs € 1,051m, +15.9% and +16.5% organic. The group benefited from a price effect of € 65m (+6% vs +€ 44m in...
>Publication du CA T3 proche de nos attentes - Lisi publie un CA T3 de 396.2 M€ (407.3 M€ estimés) vs 355.8 M€ en hausse de 11.3 et +14.8% en organique. Cette performance se compare à une hausse organique semestrielle de 17.4%. Notons que pour ce trimestre, l’effet de référence était particulièrement défavorable avec une hausse organique de 24.4% pour le trimestre de référence. Le CA 9 mois ressort à 1217.9 M€ vs 1051 M€, +15.9% et +16.5% en organique. Le groupe a bé...
Last week we held our third ODDO BHF Iberian Forum, the third since the announcement of our partnership with BBVA. The event was fully virtual and took place on 4 and 5 October. With 62 Iberian issuers, close to 180 institutional investors and more than 700 meetings, this is one of the largest dedicated Iberian conferences held this year. This note brings together 47 feedback documents, with 6 target price revisions (o/w 4 downgrades). The main subjects of debate were, on the one han...
Malgré une période de profits exceptionnels depuis 2 ans, RWE a connu une performance boursière atone (hors dividendes). Pourtant la période qui s’ouvre et les besoins d’investissements massifs sont typiquement le cocktail idéal pour la création de valeur de long terme. Le titre est passé d’une prime de 30% vs indice à une décote de 17% avec une accélération depuis septembre et les déboires de l’éolien offshore aux US. Nous estimons que les niveaux actuels sont propices à un retour su...
Despite a period of exceptional profits over the past two years, RWE’s share price performance has been flat (excluding dividends). But massive investment needs over the coming years are typically the ideal cocktail for long-term value creation. The stock’s 30% premium to the index has morphed into a 17% discount, with the downward trend accelerating since September following setbacks to US offshore wind. We think this is a good time to return to the stock at current valuation levels....
Last week we held our third ODDO BHF Iberian Forum, the third since the announcement of our partnership with BBVA. The event was fully virtual and took place on 4 and 5 October. With 62 Iberian issuers, close to 180 institutional investors and more than 700 meetings, this is one of the largest dedicated Iberian conferences held this year. This note brings together 47 feedback documents, with 6 target price revisions (o/w 4 downgrades). The main subjects of debate were, on the one han...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.